❓ Hon. Sophia Moermond asks the Minister for Health if medicinal cannabis listing on the Pharmaceutical Benefits Scheme (PBS) will be an agenda item at the next Council of Australian Governments (COAG) Health Council meeting. The Minister declines, citing established processes and the need for medicinal cannabis to meet the same standards as other funded medicines.
AnsweredQoN 325Legislative Council
QuestionView source ↗
MEDICAL CANNABIS —
PHARMACEUTICAL BENEFITS SCHEME
325. Hon SOPHIA MOERMOND to the minister representing the
Minister for Health:
I
thank the minister for his answer to my question without notice 282 on 16 June
on medicinal cannabis and the pharmaceutical benefits scheme. Further to his
answer, and the correspondence tabled and date stamped 14 November 2018,
will the minister list this as an agenda item for the next Council of Australian
Governments Health Council meeting; and, if not, why not?
PHARMACEUTICAL BENEFITS SCHEME
325. Hon SOPHIA MOERMOND to the minister representing the
Minister for Health:
I
thank the minister for his answer to my question without notice 282 on 16 June
on medicinal cannabis and the pharmaceutical benefits scheme. Further to his
answer, and the correspondence tabled and date stamped 14 November 2018,
will the minister list this as an agenda item for the next Council of Australian
Governments Health Council meeting; and, if not, why not?
AnswerView source ↗
I thank the honourable member for
some notice of the question. The following answer is provided on behalf of the
Minister for Health.
No. There is an established and
legislated process for medicines to be assessed, recommended and listed on the pharmaceutical benefits scheme. To maintain the
integrity of the PBS, medicinal cannabis products should be required to
meet the exact same standards of quality, safety, efficacy and value for money
as other funded medicines.
some notice of the question. The following answer is provided on behalf of the
Minister for Health.
No. There is an established and
legislated process for medicines to be assessed, recommended and listed on the pharmaceutical benefits scheme. To maintain the
integrity of the PBS, medicinal cannabis products should be required to
meet the exact same standards of quality, safety, efficacy and value for money
as other funded medicines.
Explore WA Government Data
Search the full archive in the free dashboard, or query programmatically via API.
Explore more
Government Gazette
Appointments, regulatory notices, planning changes.
Hansard
Debates, questions, speeches and sentiment.
Tabled Papers
Reports and documents tabled in Parliament.
Committees
Committee profiles and recent reports.
Regulations
Subsidiary legislation with filters and summaries.
Bills
Proposed laws and parliamentary progress.
Acts
Current WA legislation and summaries.
Explanatory Memoranda
Bills with EMs (text/PDF) available.
Members
MP profiles, party breakdown and rankings.
Pollie Rankings
Data-driven rankings across 19 categories.
Amendment Chains
Track how schemes and regulations evolve over time.